Quantitative structural MRI for early detection of Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Cortical Surface-Based Analysis

Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910 · see citing works

Whole Brain Segmentation

Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610 · see citing works

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

Cortical Surface-Based Analysis

Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147 · see citing works

Measuring the thickness of the human cerebral cortex from magnetic resonance images

Fischl, B. R., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,789 · see citing works

Global prevalence of dementia: a Delphi consensus study

Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336 · see citing works

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · see citing works

A nonparametric method for automatic correction of intensity nonuniformity in MRI data

Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · see citing works

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411 · see citing works

The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods

Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347 · see citing works

Automatically Parcellating the Human Cerebral Cortex

Fischl, B. R. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg087 · Cited by 4,208 · see citing works

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · see citing works

Alzheimer's Disease Neuroimaging Initiative (ADNI)

Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572 · see citing works

Neurodegenerative Diseases Target Large-Scale Human Brain Networks

Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350 · see citing works

Sequence-independent segmentation of magnetic resonance images

Fischl, B. R., Salat, D. H., van der Kouwe, A. J. W., Makris, N., Ségonne, F., Quinn, B. T., & Dale, A. M. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.016 · Cited by 2,117 · see citing works

The clinical use of structural MRI in Alzheimer disease

Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113 · see citing works

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065 · see citing works

Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach

Dale, A. M., & Sereno, M. I. (1993) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1993.5.2.162 · Cited by 2,003 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844 · see citing works

Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer

Han, X., Jovicich, J., Salat, D., van der Kouwe, A., Quinn, B., Czanner, S., Busa, E., Pacheco, J., Albert, M., Killiany, R., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.051 · Cited by 1,508 · see citing works

Neuropathology of older persons without cognitive impairment from two community-based studies

Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · see citing works

Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data

Jovicich, J., Czanner, S., Greve, D. N., Haley, E., van der Kouwe, A. J. W., Gollub, R. L., Kennedy, D. N., Schmitt, F., Brown, G. G., MacFall, J. R., et al. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.09.046 · Cited by 1,269 · see citing works

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention

Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261 · see citing works

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans

Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246 · see citing works

Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233 · see citing works

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176 · see citing works

The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., Grodstein, F., Wright, C. I., Blacker, D., Rosas, H. D., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn113 · Cited by 1,153 · see citing works

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099 · see citing works

Alzheimer's disease: strategies for disease modification

Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,060 · see citing works

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · see citing works

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · see citing works

Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease

Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 900 · see citing works

Staging of Alzheimer-Related Cortical Destruction

Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · see citing works

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., Sabbagh, M., Honig, L. S., Doody, R., van Dyck, C. H., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c67808 · Cited by 753 · see citing works

Hippocampal and entorhinal atrophy in mild cognitive impairment

Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., Santi, S. D., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 739 · see citing works

One-Year Brain Atrophy Evident in Healthy Aging

Fjell, A. M., Walhovd, K. B., Fennema-Notestine, C., McEvoy, L. K., Hagler, D. J., Holland, D., Brewer, J. B., & Dale, A. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3252-09.2009 · Cited by 692 · see citing works

2010 Alzheimer's disease facts and figures

Alzheimer's Association (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.01.009 · Cited by 692 · see citing works

Prediction of Dementia by Subjective Memory Impairment Effects of Severity and Temporal Association With Cognitive Impairment Dementia and Subjective Memory Impairment

Jessen, F. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.30 · Cited by 681 · see citing works

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

Larrieu, S., Letenneur, L., Orgogozo, J., Fabrigoule, C., Amieva, H., Carret, N. L., Barberger‐Gateau, P., & Dartigues, J. (2002) · Neurology · doi:10.1212/01.wnl.0000034176.07159.f8 · Cited by 663 · see citing works

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · see citing works

Comparing predictors of conversion and decline in mild cognitive impairment

Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616 · see citing works

CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

Strozyk, D., Blennow, K., White, L. R., & Launer, L. J. (2003) · Neurology · doi:10.1212/01.wnl.0000046581.81650.d0 · Cited by 604 · see citing works

The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans

Weiner, M. W., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L. M. J., Saykin, A. J., Morris, J. C., Cairns, N. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 599 · see citing works

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

Buerger, K., Ewers, M., Pirttila, T., Zinkowski, R., Alafuzoff, I., Teipel, S. J., DeBernardis, J., Kerkman, D., McCulloch, C., Soininen, H., et al. (2006) · Brain · doi:10.1093/brain/awl269 · Cited by 586 · see citing works

Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI

Saykin, A. J., Wishart, H. A., Rabin, L. A., Santulli, R. B., Flashman, L. A., West, J. D., McHugh, T., & Mamourian, A. C. (2006) · Neurology · doi:10.1212/01.wnl.0000234032.77541.a2 · Cited by 584 · see citing works

Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps

Apostolova, L. G., Dutton, R. A., Dinov, I. D., Hayashi, K. M., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.693 · Cited by 553 · see citing works

Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease

Fox, N. C., Black, R. S., Gilman, S., Rossor, M. N., Griffith, S. G., Jenkins, L., & Koller, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159743.08996.99 · Cited by 550 · see citing works

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

Jagust, W. J., Bandy, D., Chen, K., Foster, N. L., Landau, S. M., Mathis, C. A., Price, J. C., Reiman, E. M., Skovronsky, D., Koeppe, R. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.003 · Cited by 537 · see citing works

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

Hampel, H. J., Bürger, K., Teipel, S. J., Bokde, A. L. W., Zetterberg, H., & Blennow, K. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.08.006 · Cited by 532 · see citing works

Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

Aisen, P. S. S., Petersen, R. C., Donohue, M., Gamst, A. C., Raman, R., Thomas, R. G., Walter, S., Trojanowski, J. Q., Shaw, L. M. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.006 · Cited by 516 · see citing works

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI

Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492 · see citing works

Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia

Du, A., Schuff, N. W., Kramer, J. H., Rosen, H. J., Gorno‐Tempini, M. L., Rankin, K. P., Miller, B. L., & Weiner, M. W. (2006) · Brain · doi:10.1093/brain/awm016 · Cited by 479 · see citing works

Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline

Fan, Y., Batmanghelich, N., Clark, C. M., & Davatzikos, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.031 · Cited by 477 · see citing works

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

Morris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.269 · Cited by 476 · see citing works

Amnestic syndrome of the medial temporal type identifies prodromal AD

Sarazin, M., Berr, C., de Rotrou, J., Fabrigoule, C., Pasquier, F., Legrain, S., Michel, B. F., Puel, M., Volteau, M., Touchon, J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000279336.36610.f7 · Cited by 464 · see citing works

Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People

De Meyer, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.179 · Cited by 462 · see citing works

Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies

Vemuri, P., Gunter, J. L., Senjem, M. L., Whitwell, J. L., Kantarci, K., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.09.073 · Cited by 450 · see citing works

Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia

Jicha, G. A., Parisi, J. E., Dickson, D. W., Johnson, K., Cha, R., Ivnik, R. J., Tangalos, E. G., Boeve, B. F., Knopman, D. S., Braak, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.674 · Cited by 399 · see citing works

MRI and CSF biomarkers in normal, MCI, and AD subjects

Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., Knopman, D. S., Petersen, R. C., & Jack, C. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af79fb · Cited by 398 · see citing works

A meta-analysis of hippocampal atrophy rates in Alzheimer's disease

Barnes, J., Bartlett, J. W., van de Pol, L. A., Loy, C. T., Scahill, R. I., Frost, C. D., Thompson, P. M., & Fox, N. C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.010 · Cited by 396 · see citing works

Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer’s disease

Singh, V., Chertkow, H., Lerch, J. P., Evans, A. C., Dorr, A. E., & Kabani, N. J. (2006) · Brain · doi:10.1093/brain/awl256 · Cited by 386 · see citing works

Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging

Davatzikos, C., Fan, Y., Wu, X., Shen, D., & Resnick, S. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.010 · Cited by 385 · see citing works

Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative

Jack, C. R., Bernstein, M. A., Borowski, B., Gunter, J. L., Fox, N. C., Thompson, P. M., Schuff, N. W., Krüger, G., Killiany, R., DeCarli, C. S., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.004 · Cited by 379 · see citing works

PROMO: Real‐time prospective motion correction in MRI using image‐based tracking

White, N. S., Roddey, J. C., Shankaranarayanan, A., Han, E. T., Rettmann, D. W., Santos, J. M., Kuperman, J., & Dale, A. M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22176 · Cited by 377 · see citing works

MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study

Whitwell, J. L., Josephs, K. A., Murray, M. E., Kantarci, K., Przybelski, S. A., Weigand, S. D., Vemuri, P., Senjem, M. L., Parisi, J. E., Knopman, D. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324924.91351.7d · Cited by 376 · see citing works

Hippocampal atrophy rates in Alzheimer disease

Henneman, W. J. P., Sluimer, J. D., Barnes, J., van der Flier, W. M., Sluimer, I. C., Fox, N. C., Scheltens, P., Vrenken, H., & Barkhof, F. (2009) · Neurology · doi:10.1212/01.wnl.0000344568.09360.31 · Cited by 375 · see citing works

Reassessing the amyloid cascade hypothesis of Alzheimer's disease

Pimplikar, S. W. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.015 · Cited by 373 · see citing works

Computer-assisted imaging to assess brain structure in healthy and diseased brains

Ashburner, J., Csernansk, J. G., Davatzikos, C., Fox, N. C., Frisoni, G. B., & Thompson, P. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00304-1 · Cited by 371 · see citing works

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

Whitwell, J. L., Shiung, M. M., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000280575.77437.a2 · Cited by 357 · see citing works

Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

Fagan, A. M., Mintun, M. A., Shah, A. R., Aldea, P., Roe, C. M., Mach, R. H., Marcus, D., Morris, J. C., & Holtzman, D. M. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900048 · Cited by 353 · see citing works

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease

Whitwell, J. L., Weigand, S. D., Shiung, M. M., Boeve, B. F., Ferman, T. J., Smith, G. E., Knopman, D. S., Petersen, R. C., Benarroch, E. E., Josephs, K. A., et al. (2007) · Brain · doi:10.1093/brain/awl388 · Cited by 348 · see citing works

Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease

Reisberg, B., & Gauthier, S. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006412 · Cited by 338 · see citing works

Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment

McEvoy, L. K., Fennema-Notestine, C., Roddey, J. C., Hagler, D. J., Holland, D., Karow, D. S., Pung, C. J., Brewer, J. B., & Dale, A. M. (2009) · Radiology · doi:10.1148/radiol.2511080924 · Cited by 330 · see citing works

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study

Ridha, B. H., Barnes, J., Bartlett, J. W., Godbolt, A., Pepple, T., Rossor, M. N., & Fox, N. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70550-6 · Cited by 326 · see citing works

The cortical signature of prodromal AD

Bakkour, A., Morris, J. C., & Dickerson, B. C. (2008) · Neurology · doi:10.1212/01.wnl.0000340981.97664.2f · Cited by 315 · see citing works

Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal

Apostolova, L. G., Mosconi, L., Thompson, P. M., Green, A. E., Hwang, K., Ramírez, A., Mistur, R. L., Tsui, W. H., & de Leon, M. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.008 · Cited by 313 · see citing works

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

Trojanowski, J. Q., Vandeerstichele, H., Korecka, M., Clark, C. M., Aisen, P. S. S., Petersen, R. C., Blennow, K., Soares, H. D., Simon, A. J., Lewczuk, P., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.008 · Cited by 308 · see citing works

Regional rates of neocortical atrophy from normal aging to early Alzheimer disease

McDonald, C. R., McEvoy, L. K., Gharapetian, L., Fennema-Notestine, C., Hagler, D. J., Holland, D., Koyama, A., Brewer, J. B., & Dale, A. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b16431 · Cited by 299 · see citing works

Positron emission tomography imaging in dementia

HERHOLZ, K., CARTER, S. F., & JONES, M. (2007) · The British Journal of Radiology · doi:10.1259/bjr/97295129 · Cited by 287 · see citing works

Disease-modifying therapies for Alzheimer disease

Cummings, J. L., Doody, R. S., & Clark, C. (2007) · Neurology · doi:10.1212/01.wnl.0000295996.54210.69 · Cited by 281 · see citing works

Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration

Rabinovici, G. D., Seeley, W. W., Kim, E. J., Gorno‐Tempini, M. L., Rascovsky, K., Pagliaro, T. A., Allison, S. C., Halabi, C., Kramer, J. H., Johnson, J. K., et al. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507308779 · Cited by 256 · see citing works

MRI and CSF biomarkers in normal, MCI, and AD subjects

Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., Knopman, D. S., Petersen, R. C., & Jack, C. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af79e5 · Cited by 246 · see citing works

Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

Iqbal, K., & Grundke, I. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00225.x · Cited by 238 · see citing works

Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer’s disease

Villain, N., Fouquet, M., Baron, J.-C., Mezenge, F., Landeau, B., de La Sayette, V., Viader, F., Eustache, F., Desgranges, B., & Chetelat, G. (2010) · Brain · doi:10.1093/brain/awq203 · Cited by 237 · see citing works

Structural MRI biomarkers for preclinical and mild Alzheimer's disease

Fennema‐Notestine, C., Hagler, D. J., McEvoy, L. K., Fleisher, A. S., Wu, E. H., Karow, D. S., & Dale, A. M. (2009) · Human Brain Mapping · doi:10.1002/hbm.20744 · Cited by 233 · see citing works

Amyloid Imaging in Aging and Dementia: Testing the Amyloid HypothesisIn Vivo

Rabinovici, G. D., & Jagust, W. J. (2009) · Behavioural Neurology · doi:10.1155/2009/609839 · Cited by 224 · see citing works

Staging of Alzheimer-Related Cortical Destruction

Braak, H., & Braak, E. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004973 · Cited by 217 · see citing works

Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls

Morra, J. H., Tu, Z., Apostolova, L. G., Green, A. E., Avedissian, C., Madsen, S. K., Parikshak, N., Hua, X., Toga, A. W., Jack, C. R., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20708 · Cited by 212 · see citing works

Subregional neuroanatomical change as a biomarker for Alzheimer's disease

Holland, D., Brewer, J. B., Hagler, D. J., Fennema-Notestine, C., Dale, A. M., Initiative, T. A. D. N., Weiner, M., Thal, L., Petersen, R., Jack, C. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906053106 · Cited by 210 · see citing works

CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease

Fjell, A. M., Walhovd, K. B., Fennema‐Notestine, C., McEvoy, L. K., Hagler, D. J., Holland, D., Brewer, J. B., Dale, A. M., & Initiative, A. D. N. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3785-09.2010 · Cited by 209 · see citing works

Recent developments in Alzheimer's disease therapeutics

Rafii, M., & Aisen, P. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-7 · Cited by 204 · see citing works

Differential Cortical Atrophy in Subgroups of Mild Cognitive Impairment

Bell‐McGinty, S., López, O. L., MELTZER, C. C., Scanlon, J. M., Whyte, E. M., DeKosky, S. T., & Becker, J. T. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1393 · Cited by 196 · see citing works

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Rabinovici, G. D., & Jagust, W. J. (2009) · PubMed Central · doi:10.3233/ben-2009-0232 · Cited by 194 · see citing works

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease

Blennow, K., & Zetterberg, H. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1177 · Cited by 180 · see citing works

Atrophy rates accelerate in amnestic mild cognitive impairment

Jack, C. R., Weigand, S. D., Shiung, M. M., Przybelski, S. A., O’Brien, P. C., Gunter, J. L., Knopman, D. S., Boeve, B. F., Smith, G. E., & Petersen, R. C. (2007) · Neurology · doi:10.1212/01.wnl.0000281688.77598.35 · Cited by 175 · see citing works

Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimer Disease

Brewer, J. B., Magda, S., Airriess, C. N., & Smith, M. E. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1402 · Cited by 173 · see citing works

Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage

Vemuri, P., Whitwell, J. L., Kantarci, K., Josephs, K. A., Parisi, J. E., Shiung, M. S., Knopman, D. S., Boeve, B. F., Petersen, R. C., Dickson, D. W., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.012 · Cited by 172 · see citing works

A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease

Black, R. S., Sperling, R. A., Safirstein, B., Motter, R. N., Pallay, A., Nichols, A., & Grundman, M. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181c53b00 · Cited by 170 · see citing works

Measuring atrophy in Alzheimer disease

Schott, J. M., Price, S. L., Frost, C. D., Whitwell, J. L., Rossor, M. N., & Fox, N. C. (2005) · Neurology · doi:10.1212/01.wnl.0000167542.89697.0f · Cited by 162 · see citing works

Multi-modal imaging predicts memory performance in normal aging and cognitive decline

Walhovd, K. B., Fjell, A. M., Dale, A. M., McEvoy, L. K., Brewer, J. B., Karow, D. S., Salmon, D. P., & Fennema‐Notestine, C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.013 · Cited by 158 · see citing works

Optimizing power to track brain degeneration in Alzheimer’s disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects

Hua, X., Lee, S., Yanovsky, I., Leow, A. D., Chou, Y.-Y., Ho, A. J., Gutman, B., Toga, A. W., Jack, C. R., Bernstein, M. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.011 · Cited by 145 · see citing works

Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β

Castellani, R. J., Lee, H., Siedlak, S. L., Nunomura, A., Hayashi, T., Nakamura, M., Zhu, X., Perry, G. L., & Smith, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1151 · Cited by 140 · see citing works

Volumetric MRI and cognitive measures in Alzheimer disease

Ridha, B. H., Anderson, V. M., Barnes, J., Boyes, R. G., Price, S. L., Rossor, M. N., Whitwell, J. L., Jenkins, L., Black, R. S., Grundman, M., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0750-9 · Cited by 139 · see citing works

Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses

Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 139 · see citing works

Effect of tramiprosate in patients with mild-to-moderate alzheimer's disease: Exploratory analyses of the MRI sub-group of the alphase study

Gauthier, S. G., Aisen, P. S. S., Ferris, S. H., Saumier, D., Duong, A., Haine, D., Garceau, D., Suhy, J., Oh, J., Lau, W. C., et al. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0106-x · Cited by 136 · see citing works

Prospective motion correction of high-resolution magnetic resonance imaging data in children

Brown, T. T., Kuperman, J. M., Erhart, M. J., White, N. S., Roddey, J. C., Shankaranarayanan, A., Han, E. T., Rettmann, D. W., & Dale, A. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.017 · Cited by 125 · see citing works

Relative Capability of MR Imaging and FDG PET to Depict Changes Associated with Prodromal and Early Alzheimer Disease

Karow, D. S., McEvoy, L. K., Fennema‐Notestine, C., Hagler, D. J., Jennings, R. G., Brewer, J. B., Hoh, C. K., Dale, A. M., & Initiative, A. D. N. (2010) · Radiology · doi:10.1148/radiol.10091402 · Cited by 120 · see citing works

Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study

Nordlund, A., Rolstad, S., KLANG, O., Edman, Å., Hansen, S., & Wallin, A. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.171066 · Cited by 117 · see citing works

Fully-Automated Volumetric MRI with Normative Ranges: Translation to Clinical Practice

Brewer, J. B. (2009) · Behavioural Neurology · doi:10.1155/2009/616581 · Cited by 114 · see citing works

Novel targets for Alzheimer's disease treatment

Grill, J., & Cummings, J. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 113 · see citing works

High-throughput, Fully Automated Volumetry for Prediction of MMSE and CDR Decline in Mild Cognitive Impairment

Kovačević, S., Rafii, M. S., & Brewer, J. B. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318192e745 · Cited by 112 · see citing works

Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment

McDonald, C. R., Gharapetian, L., McEvoy, L. K., Fennema‐Notestine, C., Hagler, D. J., Holland, D., & Dale, A. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.015 · Cited by 111 · see citing works

Automated MRI measures predict progression to Alzheimer's disease

Desikan, R. S., Cabral, H., Settecase, F., Hess, C. P., Dillon, W. P., Glastonbury, C. M., Weiner, M. W., Schmansky, N. J., Salat, D. H., & Fischl, B. R. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.023 · Cited by 109 · see citing works

Brain Atrophy in Healthy Aging Is Related to CSF Levels of Aβ1-42

Fjell, A. M., Walhovd, K. B., Fennema‐Notestine, C., McEvoy, L. K., Hagler, D. J., Holland, D., Blennow, K., Brewer, J. B., Dale, A. M., & Initiative, T. A. D. N. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp279 · Cited by 105 · see citing works

Early detection of Alzheimer's disease: new diagnostic criteria

Dubois, B., Picard, G., & Sarazin, M. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/bdubois · Cited by 102 · see citing works

Hypometabolism in Alzheimer-Affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E ε4 Allele

Langbaum, J. B. S., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., Alexander, G. E., Burns, C. M., Kaszniak, A. W., Reeder, S. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.30 · Cited by 100 · see citing works

Fully-automated volumetric MRI with normative ranges: translation to clinical practice.

Brewer, J. (2009) · PubMed · doi:10.3233/ben-2009-0226 · Cited by 98 · see citing works

Longitudinal Rates of Lobar Atrophy in Frontotemporal Dementia, Semantic Dementia, and Alzheimer's Disease

Krueger, C. E., Dean, D. L., Rosen, H. J., Halabi, C., Weiner, M. W., Miller, B. L., & Kramer, J. H. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6f101 · Cited by 96 · see citing works

Temporoparietal MR Imaging Measures of Atrophy in Subjects with Mild Cognitive Impairment That Predict Subsequent Diagnosis of Alzheimer Disease

Desikan, R. S., Cabral, H. J., Fischl, B., Guttmann, C. R. G., Blacker, D., Hyman, B. T., Albert, M. S., & Killiany, R. J. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1397 · Cited by 94 · see citing works

Japanese Alzheimer's Disease Neuroimaging Initiative: Present status and future

Iwatsubo, T. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.011 · Cited by 94 · see citing works

Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD

Barnes, J., Godbolt, A. K., Frost, C. D., Boyes, R. G., Jones, B. F., Scahill, R. I., Rossor, M. N., & Fox, N. C. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.012 · Cited by 81 · see citing works

REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

Panza, F., Frisardi, V., Imbimbo, B. P., Capurso, C. A., Logroscino, G., Sancarlo, D., Seripa, D., Vendemiale, G., Pilotto, A., & Solfrizzi, V. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00164.x · Cited by 80 · see citing works

Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative

Ellis, K., Rowe, C., Villemagne, V., Martins, R., Masters, C., Salvado, O., Szoeke, C., & Ames, D. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.009 · Cited by 76 · see citing works

Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls

Murphy, E. A., Holland, D., Donohue, M., McEvoy, L. K., Hagler, D. J., Dale, A. M., & Brewer, J. B. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.07.016 · Cited by 73 · see citing works

Toward Structural Elucidation of the γ-Secretase Complex

Li, H., Wolfe, M. S., & Selkoe, D. J. (2009) · Structure · doi:10.1016/j.str.2009.01.007 · Cited by 63 · see citing works

アルツハイマー病の再検討:アミロイド-ベータタンパク質前駆体およびアミロイド-ベータの保護的役割の証拠

Ma, S., Perry, G., Xw, Z., Nakamura, M., Hayashi, T., Nunomura, A., Sl, S., Hg, L., & Castellani, R. (2009) · Journal of Alzheimers Disease · Cited by 61 · see citing works

Structural Neuroimaging in the Detection and Prognosis of Pre-Clinical and Early AD

Fennema‐Notestine, C., McEvoy, L. K., Hagler, D. J., Jacobson, M. W., Dale, A. M., & Initiative, T. A. D. N. (2009) · Behavioural Neurology · doi:10.1155/2009/698156 · Cited by 56 · see citing works

Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Fennema‐Notestine, C., McEvoy, L. K., Hagler, D. J., et al. (2009) · PubMed · doi:10.3233/ben-2009-0230 · Cited by 47 · see citing works

Combining short interval MRI in Alzheimer’s disease

Schott, J. M., Frost, C. D., Whitwell, J. L., MacManus, D. G., Boyes, R. G., Rossor, M. N., & Fox, N. C. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0173-4 · Cited by 46 · see citing works

Neuroimaging Enrichment Strategy for Secondary Prevention Trials in Alzheimer Disease

McEvoy, L. K., Edland, S. D., Holland, D., Hagler, D. J., Roddey, J. C., Fennema‐Notestine, C., Salmon, D. P., Koyama, A. K., Aisen, P. S. S., Brewer, J. B., et al. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181d1b814 · Cited by 45 · see citing works

Early risk assessment for Alzheimer's disease

Carrillo, M. C., Blackwell, A. D., Hampel, H. J., Lindborg, J., Sperling, R. A., Schenk, D., Sevigny, J., Ferris, S. H., Bennett, D. A., Craft, S., et al. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.019 · Cited by 42 · see citing works

Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: The Alzhemedtm (Tramiprosate) experience

Saumier, D., Aisen, P. S. S., Gauthier, S. G., Vellas, B. J., Ferris, S. H., Duong, A., Suhy, J., Oh, J., Lau, W. C., Garceau, D., et al. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0047-4 · Cited by 34 · see citing works

Alzheimer's Disease Neuroimaging Initiative in Europe

Frisoni, G. B. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.005 · Cited by 27 · cited 2× · see citing works

Longitudinal imaging in dementia

Scahill, R. I., & Fox, N. C. (2007) · British Journal of Radiology · doi:10.1259/bjr/78981552 · Cited by 24 · see citing works

Cognitive Phenotypes, Brain Morphometry and the Detection of Cognitive Decline in Preclinical AD

Jacobson, M. W., McEvoy, L. K., Dale, A. M., & Fennema‐Notestine, C. (2009) · Behavioural Neurology · doi:10.1155/2009/617312 · Cited by 12 · see citing works

Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD.

Jacobson, M. W., McEvoy, L. K., Dale, A. M., et al. (2009) · PubMed · doi:10.3233/ben-2009-0229 · Cited by 11 · see citing works

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Facilitating Alzheimer's disease drug development in the United States

Aisen, P. S. S. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.005 · Cited by 3 · see citing works

P1‐427: Structural neuroimaging for individual patient risk assessment in mild cognitive impairment

McEvoy, L. K., Holland, D., Hagler, D. J., Fennema‐Notestine, C., & Dale, A. M. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.982 · Cited by 1 · see citing works

Untitled work

Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works

The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786 · see citing works

Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis

Liss, J. L., Seleri Assunção, S., Cummings, J., Atri, A., Geldmacher, D. S., Candela, S. F., Devanand, D. P., Fillit, H. M., Susman, J., Mintzer, J., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13244 · Cited by 312 · see citing works

Predicting MCI outcome with clinically available MRI and CSF biomarkers

Heister, D. S., Brewer, J. B., Magda, S., Blennow, K., McEvoy, L. K., & Initiative, A. D. N. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343314 · Cited by 201 · see citing works

Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting

Tang, X., Holland, D., Dale, A. M., Laurent Younes, B., Miller, M. I., & Initiative, A. D. N. (2014) · Human Brain Mapping · doi:10.1002/hbm.22431 · Cited by 148 · see citing works

Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease: Methodology and Baseline Sample Characteristics

Byun, M. S., Yi, D., Lee, J. H., Choe, Y. M., Sohn, B. K., Lee, J., Choi, H. J., Baek, H., Kim, Y. K., Lee, Y., et al. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.6.851 · Cited by 116 · see citing works

Identifying incipient dementia individuals using machine learning and amyloid imaging

Mathotaarachchi, S., Pascoal, T. A., Shin, M., Benedet, A. L., Kang, M. S., Beaudry, T., Fonov, V. S., Gauthier, S., & Rosa-Neto, P. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.027 · Cited by 118 · see citing works

Mild Cognitive Impairment: Baseline and Longitudinal Structural MR Imaging Measures Improve Predictive Prognosis

McEvoy, L. K., Holland, D., Hagler, D. J., Fennema‐Notestine, C., Brewer, J. B., & Dale, A. M. (2011) · Radiology · doi:10.1148/radiol.11101975 · Cited by 107 · see citing works

Temporal Lobe Epilepsy: Quantitative MR Volumetry in Detection of Hippocampal Atrophy

Farid, N., Girard, H. M., Kemmotsu, N., Smith, M. E., Magda, S., Lim, W. Y., Lee, R. R., & McDonald, C. R. (2012) · Radiology · doi:10.1148/radiol.12112638 · Cited by 106 · see citing works

Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease

Williams, P. A., Thirgood, R. A., Oliphant, H., Frizzati, A., Littlewood, E., Votruba, M., Good, M. A., Williams, J. H., & Morgan, J. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.006 · Cited by 104 · see citing works

Comparison of Automated Brain Volume Measures obtained with NeuroQuant® and FreeSurfer

Ochs, A. L., Ross, D. E., Zannoni, M. D., Abildskov, T. J., & Bigler, E. D. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12229 · Cited by 88 · see citing works

Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: Association with pathology, severity, and structural brain changes

Fleszar, M. G., Wiśniewski, J., Zboch, M., Diakowska, D., Gamian, A., & Krzystek-Korpacka, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-50205-0 · Cited by 80 · see citing works

Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review

Pemberton, H., Zaki, L. A. M., Goodkin, O., Das, R., Steketee, R. M. E., Barkhof, F., & Vernooij, M. W. (2021) · Neuroradiology · doi:10.1007/s00234-021-02746-3 · Cited by 80 · see citing works

Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders

Du, L., Roy, S., Wang, P., Li, Z., Qiu, X., Zhang, Y., Yuan, J., & Guo, B. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102230 · Cited by 80 · see citing works

Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials

Holland, D., McEvoy, L. K., Desikan, R. S., Dale, A. M., & Initiative, A. D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047739 · Cited by 70 · see citing works

Predicting primary progressive aphasias with support vector machine approaches in structural MRI data

Bisenius, S., Mueller, K., Diehl-Schmid, J., Fassbender, K., Grimmer, T., Jessen, F., Kassubek, J., Kornhuber, J., Landwehrmeyer, B., Ludolph, A., et al. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.02.003 · Cited by 51 · see citing works

The quantitative neuroradiology initiative framework: application to dementia

Goodkin, O., Pemberton, H., Vos, S. B., Prados, F., Sudre, C. H., Moggridge, J. C., Cardoso, M. J., Sebastien Ourselin, A., Bisdas, S., White, M. J., et al. (2019) · British Journal of Radiology · doi:10.1259/bjr.20190365 · Cited by 49 · see citing works

Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease

Zainaghi, I. A., Talib, L. L., Diniz, B. S., Gattaz, W. F., & Forlenza, O. V. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0807-x · Cited by 46 · see citing works

Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease

Rani, S., Dhar, S. B., Khajuria, A., Gupta, D., Jaiswal, P. K., Singla, N., Kaur, M., Singh, G., & Barnwal, R. P. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01330-y · Cited by 48 · see citing works

Multi-Modal MRI Analysis with Disease-Specific Spatial Filtering: Initial Testing to Predict Mild Cognitive Impairment Patients Who Convert to Alzheimer?s Disease

Oishi, K., Akhter, K., Mielke, M. M., Ceritoglu, C., Zhang, J., Jiang, H., Li, X., Laurent Younes, B., Miller, M. I., van Zijl, P. C. M., et al. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00054 · Cited by 44 · see citing works

Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study

Pemberton, H., Goodkin, O., Prados, F., Das, R., Vos, S. B., Moggridge, J. C., Coath, W., Gordón, E., Barrett, R., Schmitt, A., et al. (2021) · European Radiology · doi:10.1007/s00330-020-07455-8 · Cited by 42 · see citing works

Study the Longitudinal in vivo and Cross-Sectional ex vivo Brain Volume Difference for Disease Progression and Treatment Effect on Mouse Model of Tauopathy Using Automated MRI Structural Parcellation

Ma, D., Holmes, H. E., Cardoso, M. J., Modat, M., Harrison, I. F., Powell, N. M., O’Callaghan, J. M., Ismail, O., Johnson, R. A., O’Neill, M. J., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00011 · Cited by 36 · see citing works

Dementia prediction with multimodal clinical and imaging data

Kubi, N. N. B. A., & Nazir, S. (2024) · International Journal of Information Technology · doi:10.1007/s41870-024-02326-7 · Cited by 29 · see citing works

Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology?

Pich, E. M., Jeromin, A., Frisoni, G. B., Hill, D., Lockhart, A., Schmidt, M. E., Turner, M. R., Mondello, S., & Potter, W. Z. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt276 · Cited by 29 · see citing works

Structure focused neurodegeneration convolutional neural network for modelling and classification of Alzheimer’s disease

Odimayo, S., Olisah, C. C., & Mohammed, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-60611-8 · Cited by 26 · see citing works

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment

Desikan, R. S., Rafii, M. S., Brewer, J. B., & Hess, C. P. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3644 · Cited by 26 · see citing works

Multifunctional bioreactive-nanoconstructs for sensitive and accurate MRI of cerebrospinal fluid pathology and intervention of Alzheimer’s disease

He, C., Ahmed, T., Abbasi, A. Z., Li, L. Y., Foltz, W. D., Cai, P., Knock, E., Fraser, P. E., Rauth, A. M., Henderson, J. T., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100965 · Cited by 24 · see citing works

Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors

Rogne, S., Vangberg, T. R., Eldevik, P., Wikran, G., Mathiesen, E. B., & Schirmer, H. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000450885 · Cited by 23 · see citing works

Epilepsy and aging

Kotloski, R. J., Dowding, J., Hermann, B. P., & Sutula, T. P. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00025-x · Cited by 23 · see citing works

Segmentation errors and intertest reliability in automated and manually traced hippocampal volumes

Brinkmann, B. H., Guragain, H., Kenney‐Jung, D. L., Mandrekar, J. N., Watson, R. E., Welker, K. M., Britton, J. W., & Witte, R. J. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50885 · Cited by 21 · see citing works

Imaging of neurodegenerative cognitive and behavioral disorders

Atri, A. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53486-6.00050-8 · Cited by 19 · see citing works

Emergence of breath testing as a new non-invasive diagnostic modality for neurodegenerative diseases

Subramaniam, N. S., Bawden, C. S., Waldvogel, H. J., Faull, R. L. M., Howarth, G. S., & Snell, R. G. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.017 · Cited by 17 · see citing works

Quantification of perforant path fibers for early detection of Alzheimer's disease

Uchida, Y., Hou, Z., Gómez-Isaza, L., Luongo, M., Troncoso, J. C., Miller, M. I., Mori, S., & Oishi, K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70142 · Cited by 16 · see citing works

Association between low thyroid-stimulating hormone, posterior cortical atrophy and nitro-oxidative stress in elderly patients with cognitive dysfunction

Bulboacă, A. E., Bolboaca, S. D., Bulboacă, A., & Prodan, C. I. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60129 · Cited by 15 · see citing works

A systematic review of (semi-)automatic quality control of T1-weighted MRI scans

Hendriks, J., Mutsaerts, H. J. M. M., Joules, R., Peña‐Nogales, Ó., Rodrigues, P., Wolz, R., Burchell, G. L., Barkhof, F., & Schrantee, A. (2023) · Neuroradiology · doi:10.1007/s00234-023-03256-0 · Cited by 15 · see citing works

Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough

McEvoy, L. K., & Brewer, J. B. (2012) · Imaging in Medicine · doi:10.2217/iim.12.27 · Cited by 15 · see citing works

Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease

Trzepacz, P. T., Hochstetler, H. M., Yu, P., Castelluccio, P., Witte, M. M., Dell’Agnello, G., Degenhardt, E. K., & Initiative, A. D. N. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000441351 · Cited by 15 · see citing works

Comparative Utility of Manual versus Automated Segmentation of Hippocampus and Entorhinal Cortex Volumes in a Memory Clinic Sample

Fung, Y. L., Ng, K. E. T., Vogrin, S. J., Meade, C. E., Ngo, M. M., Collins, S. J., & Bowden, S. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181172 · Cited by 15 · see citing works

Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer’s Disease Clinical Trials

Menéndez‐González, M., Alonso, B. D. C., Salas-Pacheco, J. M., & Arias-Carrión, Ó. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150226 · Cited by 14 · see citing works

Quantitative MRI Differences Between Early versus Late Onset Alzheimer’s Disease

Meysami, S., Raji, C. A., Merrill, D. A., Porter, V. R., & Mendez, M. F. (2021) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175211055325 · Cited by 13 · see citing works

DenseNet-Based Approach for Early Detection and Classification of Alzheimer's Disease Using MRI Images

Nasra, P., & Gupta, S. (2025) · International Conference on Pervasive Computational Technologies (ICPCT) · doi:10.1109/icpct64145.2025.10940932 · Cited by 13 · see citing works

Sensitivity and specificity of executive function tests for Alzheimer’s disease

Huang, S., Liu, C., Chang, C., & Su, C. (2016) · Applied Neuropsychology Adult · doi:10.1080/23279095.2016.1204301 · Cited by 13 · see citing works

Deep Learning–based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy

Nigro, S. L., Filardi, M., Tafuri, B., Nicolardi, M., Blasi, R. D., Giugno, A., Gnoni, V., Milella, G., Urso, D., Zoccolella, S., et al. (2024) · Radiology Artificial Intelligence · doi:10.1148/ryai.230151 · Cited by 12 · see citing works

Review of the Evidence Supporting the Medical and Legal Use of NeuroQuant® in Patients with Traumatic Brain Injury

Ross, D. E., Graham, T. J., & Ochs, A. L. (2012) · Psychological Injury and Law · doi:10.1007/s12207-012-9140-9 · Cited by 12 · see citing works

Updated Review of the Evidence Supporting the Medical and Legal Use of NeuroQuant® and NeuroGage® in Patients With Traumatic Brain Injury

Ross, D. E., Seabaugh, J. D., Seabaugh, J. M., Barcelona, J., Seabaugh, D., Wright, K., Norwind, L., King, Z., Graham, T. J., Baker, J. R., et al. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.715807 · Cited by 11 · see citing works

Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration

Kukreja, L., Shahidehpour, R. K., Kım, G., Keegan, J., Sadleir, K. R., Russell, T. A., Csernansky, J. G., Mesulam, M. M., Vassar, R. J., Wang, L., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1836-17.2018 · Cited by 11 · see citing works

Overview of MR Imaging Volumetric Quantification in Neurocognitive Disorders

Raji, C. A., Ly, M. J., & Benzinger, T. L. S. (2019) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000224 · Cited by 10 · see citing works

Exploring Survival Models Associated with MCI to AD Conversion: A Machine Learning ApproachPreprint

Orozco-Sanchez, J., Treviño, V., Martínez-Ledesma, E., Farber, J., & Tamez‐Peña, J. G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/836510 · Cited by 10 · see citing works

Artificial Intelligence in the Diagnosis of Neurological Diseases Using Biomechanical and Gait Analysis Data: A Scopus-Based Bibliometric Analysis

Tsiara, A. A., Plakias, S., Kokkotis, C., Veneri, A., Mina, M. A., Tsiakiri, A., Kitmeridou, S., Christidi, F., Gourgoulis, E., Doskas, T., et al. (2025) · Neurology International · doi:10.3390/neurolint17030045 · Cited by 20 · see citing works

Volumetric Changes in Cerebellar Transverse Zones: Age and Sex Effects in Health and Neurological Disorders

Ghiyamihoor, F., Peymani, P., Perron, J., Asemi‐Rad, A., Marzban, M., Mohite, A., Ardila, K., Aljada, B., Marzban, A., Toback, M., et al. (2025) · Human Brain Mapping · doi:10.1002/hbm.70214 · Cited by 9 · see citing works

Multimodal magnetic resonance imaging analysis of early mild cognitive impairment

Xu, S., Fan, Y., Mao, C., Hu, Z., Yang, Z., Qu, L., Xu, Y., Yu, L., Zhu, X., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251321187 · Cited by 8 · see citing works

Agreement Between Automated and Manual MRI Volumetry in Alzheimer's Disease: A Systematic Review and Meta‐Analysis

Quek, Y., Fung, Y. L., Cheung, M. W. ‐., Vogrin, S. J., Collins, S. J., & Bowden, S. C. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28037 · Cited by 8 · see citing works

A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease

Zhang, H., Zhu, F., Dodge, H. H., Higgins, G. A., Omenn, G. S., Guan, Y., & Initiative, T. A. D. N. (2018) · GigaScience · doi:10.1093/gigascience/giy085 · Cited by 7 · see citing works

A Large-scale Comparison of Cortical and Subcortical Structural Segmentation Methods in Alzheimer’s Disease: a Statistical ApproachPreprint

Zamani, J., Sadr, A., & Javadi, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256321 · Cited by 7 · see citing works

An unsupervised learning approach for clustering joint trajectories of Alzheimer's disease biomarkers: An application to ADNI Data

Sönmez, T. F., Harvey, D. J., Beckett, L. A., & Initiative, A. D. N. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14524 · Cited by 6 · see citing works

Evaluation of the biodistribution and preliminary safety profile of a novel brain-targeted manganese dioxide-based nanotheranostic system for Alzheimer’s disease

Li, L. Y., Park, E., He, C., Abbasi, A. Z., Henderson, J. T., Fraser, P. E., Uetrecht, J., Rauth, A. M., & Wu, X. Y. (2024) · Nanotoxicology · doi:10.1080/17435390.2024.2361687 · Cited by 5 · see citing works

The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly.

Kollack-Walker, S., Liu, C. Y., & Fleisher, A. (2017) · Neurologic clinics · doi:10.1016/j.ncl.2017.01.010 · Cited by 5 · see citing works

Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis

Li, F., Cheng, J., Jin, K., Zhao, L., Li, J., Wu, J., & Ren, X. (2024) · Brain and Behavior · doi:10.1002/brb3.70111 · Cited by 4 · see citing works

Distribution of Cortical Atrophy Associated with Cognitive Decline in Alzheimer’s Disease: A Cross-Sectional Quantitative Structural MRI Study from PUMCH Dementia Cohort

Mao, C., Hou, B., Li, J., Chu, S., Huang, X., Wang, J., Dong, L., Liu, C., Feng, F., Peng, B., et al. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220905145756 · Cited by 4 · see citing works

Projecting MRI brain images for the detection of Alzheimer's Disease

Martínez-Murcia, F. J., Manuel, G. J., Ramírez, J., Ignacio, &. I., Salas-Gonzalez, D., Segovia, F., & Initiative, A. D. N. (2014) · Studies in health technology and informatics · doi:10.3233/978-1-61499-474-9-225 · Cited by 4 · see citing works

Fast Brain Volumetric Segmentation from T1 MRI Scans

Anand, A., & Anand, N. (2019) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-17795-9_30 · Cited by 3 · see citing works

Early Detection of Alzheimer's disease by using the Latest TechniquesPreprint

Ahmad, S., Aijaz, M., Ahmad, M., Hafeez, A., Asif, M., Kumar, A., Al‐Taie, A., & Ansari, M. A. (2023) · doi:10.22541/essoar.168056798.85734608/v1 · Cited by 3 · see citing works

MR Brain Screening using Optimization Techniques - A Survey

Chitradevi, D., & Prabha, S. (2021) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405617666211126154101 · Cited by 2 · see citing works

Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study

Morton, H., Basu, T., Bose, C., & Reddy, P. H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220084 · Cited by 2 · see citing works

Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy

Зуева, М. В., Zhuravleva, A. N., & Bogolepova, A. N. (2021) · Ophthalmology in Russia · doi:10.18008/1816-5095-2021-2-198-207 · Cited by 2 · see citing works

High‑Resolution T2 MRI Volumetry of Medial Temporal Lobe Subregions Predicts Cognitive Decline Across the Alzheimer’s Disease Continuum

Mozafar, M., Shahbazi, S., Amirian, M. A., Shekari, K., Sepahvand, N., Esmaeili, M., Amini, A., Shakeri, S., Mirhosseini, H., Mayeli, M., et al. (2025) · Applied Neuropsychology Adult · doi:10.1080/23279095.2025.2546951 · Cited by 1 · see citing works

Easy-to-use and easy-to-interpret quality control of 3D gradient echo T1-weighted MR acquisition sequences for improved test-retest stability of MRI-based hippocampus volumetry

Buchert, R., Suppa, P., Ardekani, B. A., Bataller, F. B., Bourgeat, P., Pierrick Coupé, A., Dahnke, R., Devenyi, G. A., Eskildsen, S. F., Fischer, C., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251380301 · Cited by 1 · see citing works

Motion-Informed 3D Deep Learning Reconstruction in Patients with Cognitive Impairment

Fujita, S., Polak, D., Nickel, D. M., Splitthoff, D. N., Huang, Y., Gil, N., Buathong, S., Chiang, C.-H., Lo, W., Clifford, B., et al. (2025) · American Journal of Neuroradiology · doi:10.3174/ajnr.a8977 · Cited by 1 · see citing works

Alzheimer's Disease Diagnosis using a Multimodal Approach with 3D MRI and PET

Ilias, L., Vozinaki, A.-M., Ntanos, C., & Askounis, D. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11357133 · Cited by 1 · see citing works

Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy

Зуева, М. В., Zhuravleva, A. N., & Bogolepova, A. N. (2022) · Ophthalmology in Russia · doi:10.18008/1816-5095-2022-3-532-540 · Cited by 1 · see citing works

Contemporary Trends in MRI and PET Imaging for the Early Diagnosis of Alzheimer’s Disease

Chan, B. (2022) · International journal of high school research · doi:10.36838/v4i6.2 · Cited by 1 · see citing works

COMPUTERIZED TOOLS: A SUBSTITUTE OR A SUPPLEMENT WHEN DIAGNOSING ALZHEIMER'S DISEASE?

Palomeque, A., & Alberto, C. (2015) · Figshare

Diagnosis of Alzheimer’s Disease Using Brain Imaging: State of the Art

Shah, A., Niaz, K., Ahmed, M., & Bunyan, R. F. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_7

An empirical study of digital signal filtering to improve Alzheimer’s disease detection

Gonzales, C., & Rodriguez, B. M. (2022) · SPIE Applications of Machine Learning · doi:10.1117/12.2643563

A Survey on Optimization Methods Used for Early Prediction and Diagnosis of Schizophrenia Disorder

Swathi, N., & Prabha, S. (2023) · Lecture notes in electrical engineering · doi:10.1007/978-3-031-42685-8_15

Brain Qualitative and Quantitative Radiological Biomarker Association with Cognitive Impairment and Dementia. Summary of the Doctoral Thesis

Zdanovskis, N. (2023) · doi:10.25143/prom-rsu_2023-20_pdk · Cited by 1 · see citing works

Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer’s disease (AD) via data fusion and machine learningPreprint

Gurmendi, D. S. M. R., Fumagal-González, G. A., Orozco-Sanchez, J., Farber, J., Treviño, V., Martínez-Ledesma, E., Martínez‐Torteya, A., Rosales-Gurmendi, F., Tamez‐Peña, J. G., & Initiative, A. D. N. (2025) · medRxiv · doi:10.1101/2025.03.11.25323801

Structural Neuroimaging Markers of Dementia: Insights from ROC Curve AnalysisPreprint

Pepper, S., Dzesu, S., Yoksh, L., Patel, A., Honea, R. A., & Mudaranthakam, D. P. (2025) · Research Square · doi:10.21203/rs.3.rs-7418658/v1

Map the image: Machine learning for quantitative MR mapping

Feng, L., Pei, H., & Liu, F. (2025) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-443-14109-6.00010-9

Enhanced Hybrid Deep Learning Model for Alzheimer Disease Diagnosis

N, B. M. T., Nayana, B. R., & Deepak, S. (2025) · International Conference on Communication, Computer, and Information Technology (IC3IT) · doi:10.1109/ic3it66137.2025.11340957

Learning Based Diagnosis of Alzheimer's Disease Using Genomic Data

Jayasingh, B. B., & Mallick, S. (2025) · International Conference on Networks and Soft Computing (ICNSoC) · doi:10.1109/icnsoc66817.2025.00102

Automatic segmentation and shape analysis of human hippocampus in Alzheimer's disease

Shen, K. (2011) · doi:10.70675/44a642b1z9128z4596z92f8z0f9767a16911

Small-Data Deep Learning for Alzheimer-Spectrum Classification from Structural MRI: A Feasibility Study Using OASIS

Li, I. D., Ung, C. Y., & Correia, C. (2026) · Journal of Imaging · doi:10.3390/jimaging12080352

AI-Driven Diagnosis of Neurological Disorders: A Comparative Study of ML and DL Techniques

Berradi, M., Malali, H. E., Youssef, Y. B., Taleb, L. B., Indjaren, H., & Mouhsen, A. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-11411-2_15

A Bayesian Sparse Kronecker Product Decomposition Framework for Tensor Predictors With Mixed‐Type Responses: Applications to Neuroimaging Data Mining

Wang, S.-H., & Huang, H. (2026) · Statistical Analysis and Data Mining The ASA Data Science Journal · doi:10.1002/sam.70106

Optimized Convolutional Neural Networks for Alzheimer's Disease Classification: Integrating Attention Mechanisms and Transfer Learning

Chen, L. (2026) · IEEE International Conference on Electronics, Energy Systems and Power Engineering (EESPE) · doi:10.1109/eespe68405.2026.11649052

The impact of biomarkers on the pre-diagnosis and treatment of Alzheimer’s disease: A comprehensive review

Mittal, A., Bhadana, P., Pathak, A., Paramanick, D., Gadewar, M. M., & Chaudhary, H. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100707

A Three-Item Oral Function Impairment Score Is Associated with White Matter, but Not Gray Matter, Volume Ratio in Older Adults: A Cross-Sectional Study

Matsumura, A., Tamura, Y., NARITA, N., Matsumiya, T., Kubota, K., Yanagidate, K., Yamaki, Y., Mori, S., Watanabe, K., Shintaku, T., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15218252

High-Performance DenseNet201 Architecture for Precise Alzheimer's Disease Classification Using Multi-Class Brain MRI Image Analysis Today

Tuteja, G., Keerthi, M. M., Gopal, L., Agarwal, V., Singh, P., Nisha, & Gupta, R. (2026) · doi:10.1109/incect72370.2026.11742584

Alzheimer's disease

Unschuld, P. G. (2026) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-443-21425-7.00014-2

Quantitative MR Imaging in Alzheimer Disease

Ramani, A., Jensen, J. H., & Helpern, J. A. (2006) · Radiology · doi:10.1148/radiol.2411050628 · Cited by 111 · see citing works

Structural Neuroimaging in the Detection and Prognosis of Pre-Clinical and Early AD

Fennema‐Notestine, C., McEvoy, L. K., Hagler, D. J., Jacobson, M. W., Dale, A. M., & Initiative, T. A. D. N. (2009) · Behavioural Neurology · doi:10.1155/2009/698156 · Cited by 56 · see citing works

Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment

McEvoy, L. K., Fennema-Notestine, C., Roddey, J. C., Hagler, D. J., Holland, D., Karow, D. S., Pung, C. J., Brewer, J. B., & Dale, A. M. (2009) · Radiology · doi:10.1148/radiol.2511080924 · Cited by 330 · see citing works

Early diagnosis of alzheimer’s disease: contribution of structural neuroimaging

Chételat, G., & Baron, J. (2003) · NeuroImage · doi:10.1016/s1053-8119(02)00026-5 · Cited by 442 · see citing works

Magnetic Resonance Imaging Based Clinical Research in Alzheimer's Disease

Fayed, N. M., Modrego, P. J., Salinas, G. R., & Gazulla, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111292 · Cited by 28 · see citing works